Suggested Topics within your search.
Suggested Topics within your search.
- COVID-19
- COVID-19 (Disease) 13
- Treatment
- drug therapy
- SARS-CoV-2 10
- Chemotherapy 7
- Coronavirus infections 7
- therapeutic use 7
- Development 6
- Antiviral Agents 5
- Antiviral agents 5
- Clinical trials 5
- Coronavirus Infections 5
- drug effects 5
- immunology 5
- Betacoronavirus 4
- Drug Development 4
- Research 4
- Therapeutic use 4
- COVID-19 Vaccines 3
- Clinical Trials as Topic 3
- Complications 3
- Immunological aspects 3
- Pneumonia, Viral 3
- Vaccination 3
- administration & dosage 3
- complications 3
- epidemiology 3
- prevention & control 3
- Anti-Bacterial Agents 2
-
1
Reaching the missing millions through public-private mix (PPM) for TB prevention and care
Published 2022Get full text
Series
Electronic Video -
2
New concepts in the management of CAP a focus on severe illness. Part 1 of 2, Treatment and therapies /
Published 2022Get full text
Series
Electronic Video -
3
New concepts in the management of CAP a focus on severe illness. Part 2 of 2, MRSA and MDR pathogens /
Published 2022Get full text
Series
Electronic Video -
4
SARS-COV-2 human monoclonal antibody therapy update
Published 2021Get full text
Series
Electronic Audio -
5
The immune system response to the SARS-CoV-2 virus March 2021 update /
Published 2021Get full text
Series
Electronic Audio -
6
-
7
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Get full text
Series
Electronic Audio -
8
-
9
INFbeta therapy for COVID-19 the new SNG001 drug /
Published 2020Get full text
Series
Electronic Audio -
10
-
11
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Published 2020Get full text
Series
Electronic Audio -
12
COVID-19 epidemiology and potential treatments follow up interview /
Published 2020Get full text
Series
Electronic Audio -
13
SARS-COV-2 what we need to know and possible future therapies /
Published 2020Get full text
Series
Electronic Audio